欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2006, Vol. 11 ›› Issue (2): 215-222.

• 研究原著 • 上一篇    

联用丙磺舒对头孢克洛药动学的影响

栾家杰, 马张庆, 汪五三, 桂常青, 宋建国   

  1. 皖南医学院定量药理研究室, 芜湖 241001, 安徽
  • 收稿日期:2005-11-17 修回日期:2006-01-10 出版日期:2006-02-06 发布日期:2020-10-26

Effects of co-administering probenecid orally on pharmacokinetics of cefaclor in rabbits

LUAN Jia-jie, MA Zhang-qing, WANG Wu-san, GUI Chang-qing, SONG Jian-guo   

  1. Laboratory of Quantitative Pharmacology, Wannan Medical College, Wuhu 241001 , Anhui, China
  • Received:2005-11-17 Revised:2006-01-10 Online:2006-02-06 Published:2020-10-26
  • Contact: SONG Jian-guo, correspondent author, male, professor, postgraduate advi- sor, specialized in mathematical pharmacology and chronopharmacology . Tel:0553-3932264 E-mail:luanjiajie@hotmail.com E-mail:luanjiajie@hotmail.com
  • About author:LUAN Ji a-jie, male, postgraduate, major in mathematical pharmacology . Tel:(0) 13004058167 E-mail:luanjiajie7570@yahoo.com .cn SONG Jian-guo, correspondent author, male, professor, postgraduate advi- sor, specialized in mathematical pharmacology and chronopharmacology . Tel:0553-3932264 E-mail:luanjiajie@hotmail.com

摘要: 目的 :研究与不同剂量丙磺舒( Probenecid) 联 用对头孢克洛( Cefaclor) 药动学的影响及其定量关 系, 并探讨其可能机制。方法:头孢克洛血、尿药浓 度监测 :雄性家兔 24 只, 随机分成 4 组 。各组给药 剂量如下:Ⅰ组头孢克洛 50 mg·kg-1 ;Ⅱ组头孢克洛 50 mg·kg -1 联用丙磺舒 100 mg·kg -1 ;Ⅲ组头孢克洛 50 mg·kg -1 联用丙磺舒 250 mg·kg -1 ;Ⅳ组头孢克洛 50 mg·kg -1联用丙磺舒 625 mg·kg -1 。灌胃给予丙磺 舒 0 .5 h 后, 再给予头孢克洛, 于用药后不同时间取 血、尿液样本。HPLC 法测定头孢克洛血药及尿药浓 度, DAS 软件计算药动学参数 。血浆蛋白结合率测 定:实验分组及剂量同上, 给药 1 h 后取血, 以平衡 透析法测定头孢克洛血浆蛋白结合率 。结果:当丙 磺舒联用剂量在 0 ~ 250 mg·kg -1 范围内时, 随丙磺 舒联用剂量增大, 头孢克洛的 T1/ 2ka 、Tmax 、Cmax 、AUC 等参数相应增大而 CL/F 及 Vd/F 相应降低( P < 0 .01) ;但当丙磺舒联用剂量达 625 mg·kg -1时, 头孢 克洛的 Cmax 降低( P <0 .01) , AUC 、CL F 则稳定于联 用丙磺舒 250 mg·kg -1 时的水平。在本实验剂量范 围内, 随丙磺舒联用剂量增大, 头孢克洛原型尿排泄 峰时间逐渐后移, 生物半衰期延长及总尿药排泄率 显著降低( P <0 .01) 。丙磺舒联用剂量在 0 ~ 250 mg·kg -1范围内, 随丙磺舒联用剂量增大, 头孢克洛 血浆蛋白结合率显著降低( P <0 .01) , 但当丙磺舒 联用剂量达 625 mg·kg -1时, 头孢克洛血浆蛋白结合 率反与头孢克洛单用时水平相当( P >0 .05) 。结 论 :联用丙磺舒可以明显改变头孢克洛的药动学过 程, 使其 Vd 、CL 降低, Cmax增高, AUC 增大, 生物半衰 期延长, 总尿药排泄率降低 。

关键词: 丙磺舒, 头孢克洛 , 药物动力学, 尿药浓度, 平衡透析法 , 血浆蛋白结合率

Abstract: AIM:To investigate the effects and quantitative relations of co-administering probenecid OF different dosages on pharmacokinetics of cefaclor in rab- bits and approach the possible mechanisms involved as well.METHODS:Monitor plasma and urine cefaclor concentrations .24 male rabbits were randomly divided in- to 4 groups by Cefaclor 50 mg·kg -1 , Cefaclor 50 mg·kg -1 + Probenecid 100 mg·kg-1 , Cefaclor 50 mg·kg -1 +Probenecid 250 mg·kg -1 and Cefaclor 50 mg·kg -1 +Probenecid 625 mg·kg -1 .Blood and urine samples were collected according to the regular time schedule after intragastric administration .The concentra- tion of cefaclor in blood and urine were determined by HPLC.Pharmacokinetic parameters were calculated by DAS ( Drug and Statistical) software .Measur plasma pro- tein-binding rate of cefaclor .The experimental groups and drug dosage were same as described above.The blood sample was drawn at 1 hour after administration, and the protein-binding rate of cefaclor was determined by equi- librium dialysis .RESULTS:Within the dosages of pro- benecid ranged from 0 -250 mg·kg -1 , T1/ 2ka, Tmax, Cmax and AUC of cefaclor increased in accordance with increas- ing dosage of co-administering probenecid while CL/F and Vd/F were decreased ( P <0 .01) ;However, when the dosage of co-administering probenecid was 625 mg·kg -1 , Cmax of cefaclor strikingly decreased ( P <0 .01) , while AUC and CL/F maintained at the levels of those with pro- benecid 250 mg·kg -1 .In this experiment, urinary excre- tive peak time of cefaclor in its prototype postponed grad- ually, biological half life prolonged and urinary excretive accumulation percentage decreased obviously( P <0 .01) . To the dosages of probenecid ranging from 0 -250 mg·kg -1 , protein-binding rate of cefaclor decreased nota- bly( P <0 .01)going with increasing dosages of co-admin- istration probenecid ;While the dosage of co-administra- tion probenecid reached 625 mg·kg -1 , the protein-bind- ing rate of cefaclor corresponded to that of cefaclor 50 mg·kg -1 without probenecid ( P >0 .05) .CONCLU- SION:Co-administering probenecid can strikingly change pharmacokinetics of cefaclor and the influential degree of pharmacokinetics parameters is dependent on dosages of probenecid used in the experiment .Biological half life prolongs and urinary excretive accumulation percentage of cefaclor decreases obviously .

Key words: probenecid , cefaclor , pharmacokinet- ics , urine drug level , HPLC , equilibrium dialysis , pro- tein-binding rate ofcefaclor

中图分类号: